Antibiotic treatment in cystic fibrosis: Part 2: Dose optimization

Johan W. Mouton*, Daniël J. Touw, Alexander A.T.M.M. Vinks, Alphons M. Horrevorts, Harry G.M. Heijerman

*Corresponding author for this work

Research output: Contribution to journalBook/Film/Article reviewProfessional

Original languageEnglish
Pages (from-to)33-37
Number of pages5
JournalAntimicrobics and Infectious Diseases Newsletter
Issue number5
Publication statusPublished - May-2000


  • aminoglycoside antibiotic agent
  • aztreonam
  • beta lactam antibiotic
  • ceftazidime
  • quinoline derived antiinfective agent
  • tobramycin
  • area under the curve
  • convulsion
  • cystic fibrosis
  • drug efficacy
  • drug half life
  • drug induced disease
  • drug mechanism
  • drug metabolism
  • human
  • lung infection
  • minimum inhibitory concentration
  • nephrotoxicity
  • ototoxicity
  • Pseudomonas aeruginosa
  • review

Cite this